Skip to main content
NCBI home page
Genitourinary Medicine logoLink to Genitourinary Medicine
. 1991 Apr;67(2):162–171. doi: 10.1136/sti.67.2.162

Feedback from the Sixth International AIDS Conference, San Francisco 1990.

PMCID: PMC1194655  PMID: 1674495

Full text

PDF
162

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bird A. G. Monitoring of lymphocyte subpopulation changes in the assessment of HIV infection. Genitourin Med. 1990 Jun;66(3):133–137. doi: 10.1136/sti.66.3.133. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Collier A. C., Bozzette S., Coombs R. W., Causey D. M., Schoenfeld D. A., Spector S. A., Pettinelli C. B., Davies G., Richman D. D., Leedom J. M. A pilot study of low-dose zidovudine in human immunodeficiency virus infection. N Engl J Med. 1990 Oct 11;323(15):1015–1021. doi: 10.1056/NEJM199010113231502. [DOI] [PubMed] [Google Scholar]
  3. Fischl M. A., Parker C. B., Pettinelli C., Wulfsohn M., Hirsch M. S., Collier A. C., Antoniskis D., Ho M., Richman D. D., Fuchs E. A randomized controlled trial of a reduced daily dose of zidovudine in patients with the acquired immunodeficiency syndrome. The AIDS Clinical Trials Group. N Engl J Med. 1990 Oct 11;323(15):1009–1014. doi: 10.1056/NEJM199010113231501. [DOI] [PubMed] [Google Scholar]
  4. Fischl M. A., Richman D. D., Hansen N., Collier A. C., Carey J. T., Para M. F., Hardy W. D., Dolin R., Powderly W. G., Allan J. D. The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection. A double-blind, placebo-controlled trial. The AIDS Clinical Trials Group. Ann Intern Med. 1990 May 15;112(10):727–737. doi: 10.7326/0003-4819-112-10-727. [DOI] [PubMed] [Google Scholar]
  5. Galgiani J. N. Fluconazole, a new antifungal agent. Ann Intern Med. 1990 Aug 1;113(3):177–179. doi: 10.7326/0003-4819-113-3-177. [DOI] [PubMed] [Google Scholar]
  6. Larder B. A., Darby G., Richman D. D. HIV with reduced sensitivity to zidovudine (AZT) isolated during prolonged therapy. Science. 1989 Mar 31;243(4899):1731–1734. doi: 10.1126/science.2467383. [DOI] [PubMed] [Google Scholar]
  7. Larder B. A., Kemp S. D. Multiple mutations in HIV-1 reverse transcriptase confer high-level resistance to zidovudine (AZT). Science. 1989 Dec 1;246(4934):1155–1158. doi: 10.1126/science.2479983. [DOI] [PubMed] [Google Scholar]
  8. Leoung G. S., Feigal D. W., Jr, Montgomery A. B., Corkery K., Wardlaw L., Adams M., Busch D., Gordon S., Jacobson M. A., Volberding P. A. Aerosolized pentamidine for prophylaxis against Pneumocystis carinii pneumonia. The San Francisco community prophylaxis trial. N Engl J Med. 1990 Sep 20;323(12):769–775. doi: 10.1056/NEJM199009203231201. [DOI] [PubMed] [Google Scholar]
  9. McArthur J. C., Cohen B. A., Selnes O. A., Kumar A. J., Cooper K., McArthur J. H., Soucy G., Cornblath D. R., Chmiel J. S., Wang M. C. Low prevalence of neurological and neuropsychological abnormalities in otherwise healthy HIV-1-infected individuals: results from the multicenter AIDS Cohort Study. Ann Neurol. 1989 Nov;26(5):601–611. doi: 10.1002/ana.410260504. [DOI] [PubMed] [Google Scholar]
  10. McArthur J. C., Cohen B. A., Selnes O. A., Kumar A. J., Cooper K., McArthur J. H., Soucy G., Cornblath D. R., Chmiel J. S., Wang M. C. Low prevalence of neurological and neuropsychological abnormalities in otherwise healthy HIV-1-infected individuals: results from the multicenter AIDS Cohort Study. Ann Neurol. 1989 Nov;26(5):601–611. doi: 10.1002/ana.410260504. [DOI] [PubMed] [Google Scholar]
  11. Selnes O. A., Miller E., McArthur J., Gordon B., Muñoz A., Sheridan K., Fox R., Saah A. J. HIV-1 infection: no evidence of cognitive decline during the asymptomatic stages. The Multicenter AIDS Cohort Study. Neurology. 1990 Feb;40(2):204–208. doi: 10.1212/wnl.40.2.204. [DOI] [PubMed] [Google Scholar]
  12. Volberding P. A., Lagakos S. W., Koch M. A., Pettinelli C., Myers M. W., Booth D. K., Balfour H. H., Jr, Reichman R. C., Bartlett J. A., Hirsch M. S. Zidovudine in asymptomatic human immunodeficiency virus infection. A controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. The AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases. N Engl J Med. 1990 Apr 5;322(14):941–949. doi: 10.1056/NEJM199004053221401. [DOI] [PubMed] [Google Scholar]

Articles from Genitourinary Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES